Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Enanta Pharmaceuticals - 11 Year Stock Price History | ENTA

Historical daily share price chart and data for Enanta Pharmaceuticals since 2013 adjusted for splits and dividends. The latest closing stock price for Enanta Pharmaceuticals as of April 19, 2024 is 13.32.
  • The all-time high Enanta Pharmaceuticals stock closing price was 126.37 on July 09, 2018.
  • The Enanta Pharmaceuticals 52-week high stock price is 37.75, which is 183.4% above the current share price.
  • The Enanta Pharmaceuticals 52-week low stock price is 8.08, which is 39.3% below the current share price.
  • The average Enanta Pharmaceuticals stock price for the last 52 weeks is 15.77.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Enanta Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 13.7486 10.0800 17.4600 10.0800 13.3200 41.55%
2023 25.5605 45.7500 54.5900 8.1800 9.4100 -79.77%
2022 55.8189 74.1100 76.9300 38.1300 46.5200 -37.79%
2021 56.8013 42.1000 97.3700 41.0200 74.7800 77.62%
2020 49.3329 62.0000 62.0000 40.2200 42.1000 -31.85%
2019 78.8125 72.3600 105.6600 57.9500 61.7800 -12.78%
2018 88.5327 57.9700 126.3700 57.9100 70.8300 20.71%
2017 38.3781 34.3500 59.3700 27.7200 58.6800 75.16%
2016 26.4514 34.1900 34.5300 21.0000 33.5000 1.45%
2015 38.3263 50.4500 51.2600 23.9000 33.0200 -35.06%
2014 39.8224 28.2800 51.9800 28.2800 50.8500 86.40%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.280B $0.079B
Enanta Pharmaceuticals, Inc. is a biotechnology company. It engages in the research and development of molecule drugs for the treatment of infectious diseases such as hepatitis C virus, respiratory tract infections, intravenous and oral treatments. Enanta Pharmaceuticals, Inc. is headquartered in Watertown, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $70.026B 28.78
Chugai Pharmaceutical (CHGCY) Japan $53.561B 23.26
Takeda Pharmaceutical (TAK) Japan $41.649B 6.75
Merck (MKGAF) Germany $20.517B 19.36
Astellas Pharma (ALPMY) Japan $17.138B 24.28
Shionogi (SGIOY) Japan $14.066B 12.17
Sandoz Group AG (SDZNY) Switzerland $13.508B 0.00
Neurocrine Biosciences (NBIX) United States $13.189B 54.77
United Therapeutics (UTHR) United States $11.150B 11.94
Catalent (CTLT) United States $10.098B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.652B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.884B 6.98
Ionis Pharmaceuticals (IONS) United States $5.948B 0.00
Revolution Medicines (RVMD) United States $5.901B 0.00
Orion OYJ (ORINY) Finland $5.081B 21.43
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.422B 0.00
Alpine Immune Sciences (ALPN) United States $4.223B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.994B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.801B 0.00
Indivior (INDV) United States $2.587B 12.03
Evotec AG (EVO) Germany $2.534B 0.00
Summit Therapeutics (SMMT) United States $2.463B 0.00
Corcept Therapeutics (CORT) United States $2.346B 23.85
Dyne Therapeutics (DYN) United States $2.038B 0.00
PTC Therapeutics (PTCT) United States $1.891B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.810B 18.71
Fusion Pharmaceuticals (FUSN) Canada $1.803B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.736B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.735B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.646B 9.75
Taro Pharmaceutical Industries (TARO) Israel $1.586B 27.76
Avadel Pharmaceuticals (AVDL) Ireland $1.574B 0.00
Ardelyx (ARDX) United States $1.499B 0.00
4D Molecular Therapeutics (FDMT) United States $1.268B 0.00
Pacira BioSciences (PCRX) United States $1.214B 12.08
Soleno Therapeutics (SLNO) United States $1.206B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.190B 11.18
Xencor (XNCR) United States $1.158B 0.00
Collegium Pharmaceutical (COLL) United States $1.137B 7.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.056B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.928B 0.00
Cronos Group (CRON) Canada $0.921B 0.00
Cassava Sciences (SAVA) United States $0.916B 0.00
Ocular Therapeutix (OCUL) United States $0.871B 0.00
USANA Health Sciences (USNA) United States $0.836B 13.17
Enliven Therapeutics (ELVN) United States $0.827B 0.00
ARS Pharmaceuticals (SPRY) United States $0.814B 0.00
Relay Therapeutics (RLAY) United States $0.802B 0.00
Sage Therapeutics (SAGE) United States $0.783B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.696B 0.00
Savara (SVRA) United States $0.662B 0.00
Silence Therapeutics (SLN) United Kingdom $0.659B 0.00
Lyell Immunopharma (LYEL) United States $0.592B 0.00
Siga Technologies (SIGA) United States $0.585B 8.66
Verve Therapeutics (VERV) United States $0.557B 0.00
ProKidney (PROK) United States $0.550B 0.00
OmniAb (OABI) United States $0.538B 0.00
Korro Bio (KRRO) United States $0.536B 0.00
Exscientia (EXAI) United Kingdom $0.527B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.526B 0.00
Altimmune (ALT) United States $0.488B 0.00
KalVista Pharmaceuticals (KALV) United States $0.485B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.447B 0.00
Heron Therapeutics (HRTX) United States $0.407B 0.00
Larimar Therapeutics (LRMR) United States $0.407B 0.00
Tourmaline Bio (TRML) United States $0.402B 0.00
Lexeo Therapeutics (LXEO) United States $0.398B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.384B 0.00
Harrow (HROW) United States $0.384B 0.00
Organogenesis (ORGO) United States $0.377B 71.50
Bioventus (BVS) United States $0.360B 0.00
Esperion Therapeutics (ESPR) United States $0.354B 0.00
Nature's Sunshine Products (NATR) United States $0.352B 19.68
Aquestive Therapeutics (AQST) United States $0.330B 0.00
Lyra Therapeutics (LYRA) United States $0.322B 0.00
Fractyl Health (GUTS) United States $0.315B 0.00
ESSA Pharma (EPIX) Canada $0.297B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.293B 0.00
Akebia Therapeutics (AKBA) United States $0.291B 0.00
Metagenomi (MGX) United States $0.290B 0.00
Black Diamond Therapeutics (BDTX) United States $0.274B 0.00
Pyxis Oncology (PYXS) United States $0.263B 0.00
Adherex Technologies (FENC) United States $0.259B 0.00
Nanobiotix S.A (NBTX) France $0.259B 0.00
Xeris Biopharma Holdings (XERS) United States $0.247B 0.00
Nektar Therapeutics (NKTR) United States $0.242B 0.00
Acrivon Therapeutics (ACRV) United States $0.239B 0.00
Telomir Pharmaceuticals (TELO) United States $0.235B 0.00
Foghorn Therapeutics (FHTX) United States $0.235B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Avita Medical (RCEL) United States $0.228B 0.00
Conduit Pharmaceuticals (CDT) United States $0.218B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.209B 0.00
Zevra Therapeutics (ZVRA) United States $0.195B 0.00
Century Therapeutics (IPSC) United States $0.193B 0.00
Profound Medical (PROF) Canada $0.192B 0.00
Prelude Therapeutics (PRLD) United States $0.189B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.184B 0.00
MediWound (MDWD) Israel $0.161B 0.00
Achieve Life Sciences (ACHV) Canada $0.157B 0.00
Incannex Healthcare (IXHL) Australia $0.151B 0.00
CytoDyn (CYDY) United States $0.150B 0.00
Karyopharm Therapeutics (KPTI) United States $0.147B 0.00
VAXART, INC (VXRT) United States $0.146B 0.00
Regulus Therapeutics (RGLS) United States $0.145B 0.00
Elite Pharmaceuticals (ELTP) United States $0.143B 13.35
GlycoMimetics (GLYC) United States $0.139B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.134B 2.83
Relmada Therapeutics (RLMD) United States $0.130B 0.00
Citius Pharmaceuticals (CTXR) United States $0.128B 0.00
Inotiv (NOTV) United States $0.121B 0.00
Eliem Therapeutics (ELYM) United States $0.116B 0.00
FibroGen (FGEN) United States $0.116B 0.00
Cardiol Therapeutics (CRDL) Canada $0.114B 0.00
OptiNose (OPTN) United States $0.105B 0.00
Vivani Medical (VANI) United States $0.099B 0.00
ProPhase Labs (PRPH) United States $0.098B 0.00
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
AlloVir (ALVR) United States $0.085B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.084B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.077B 0.00
Assertio Holdings (ASRT) United States $0.072B 5.80
Journey Medical (DERM) United States $0.071B 0.00
Carisma Therapeutics (CARM) United States $0.071B 0.00
Tempest Therapeutics (TPST) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Mural Oncology (MURA) $0.060B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.059B 0.00
SCYNEXIS (SCYX) United States $0.053B 0.79
BioLineRx (BLRX) Israel $0.051B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Jaguar Animal Health (JAGX) United States $0.049B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
Unicycive Therapeutics (UNCY) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
Viracta Therapeutics (VIRX) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
VYNE Therapeutics (VYNE) United States $0.032B 0.00
JanOne (JAN) United States $0.032B 0.00
Nutriband (NTRB) United States $0.032B 0.00
Protara Therapeutics (TARA) United States $0.031B 0.00
CASI Pharmaceuticals (CASI) China $0.030B 0.00
Lipocine (LPCN) United States $0.029B 0.00
NRx Pharmaceuticals (NRXP) United States $0.029B 0.00
DURECT (DRRX) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 11.00
Oncternal Therapeutics (ONCT) United States $0.023B 0.00
CERo Therapeutics Holdings (CERO) United States $0.023B 0.00
Addex Therapeutics (ADXN) Switzerland $0.022B 0.00
TherapeuticsMD (TXMD) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.022B 1.09
Indaptus Therapeutics (INDP) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
Alaunos Therapeutics (TCRT) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.019B 0.00
Surrozen (SRZN) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.019B 0.00
Talphera (TLPH) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Dominari Holdings (DOMH) United States $0.017B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
Inhibikase Therapeutics (IKT) United States $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.013B 0.00
Biomerica (BMRA) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.010B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.19
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 45.81